Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI | PowerRating), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals will attend Lazard Capital Markets 7th AnnualHealthcare Conference from November 16 - 17, 2010 at the St. Regis Hotel in New York.
Dr. James Jiayuan Tong, Tianyin's Chief Financial Officer, Chief Business & Development Officer and Director is invited to present at 2:45 pm on November 17, at Fontainebleau of the St. Regis at 2 East 55th Street, New York, NY 10022.
About Tianyin Pharmaceuticals
Tianyin Pharmaceutical Co., Inc., headquartered at Chengdu, China, is a pharmaceutical company that specializes in the development, manufacturing, marketing and sales of patented biopharmaceutical medicine, modernized traditional Chinese medicines, branded generics and other pharmaceuticals. Tianyin currently manufactures a comprehensive portfolio of 56 products, 23 of which are listed in the highly selective national medicine reimbursement list, 7 are included in the essential drug list of China. Tianyin currently has a pipeline of 10 late stage products pending the SFDA approval that target various high incidence healthcare indications. Tianyin has an extensive nationwide distribution network with a sales force of 730 sales representatives out of totaled 1,365 employees.
No comments:
Post a Comment